INTRODUCTION
The role of free radicals and active oxygen is becoming increasingly recognized in the pathogenesis of many human diseases, including cancer, aging and atherosclerosis 1 . Human body can be protected from these harmful compounds by enzymatic system, catalase, scavengers and antioxidants. Antioxidants are capable of preventing oxidative processes by inhibiting the initiation and propagation of an oxidative chain reaction. They are important in the prevention of many oxidative-stress related diseases 2 . Several studies have shown that the therapeutic effects of some medicinal plants, fruits and even vegetables which are commonly used in folklore remedies against many diseases can be attributed to the antioxidant properties of their phytoconstituents 3, 4 .
An extract of vine Ipomoea squamosa, a member of the Morning Glory genus, has been found to exhibitis strong cytotoxicity. After initial investigations by the then pharmaceutical partner Bristol-Myers Squibb, the extract was reinvestigated at Virginia Polytechnic Institute and State University and was found to contain a series of six resin glycosides named Ipomoeassins A-F with potent antiproliferative activities 5 . The compounds were biologically interesting because in spite of their very similar chemical structures, they had antiproliferative activities differing by about 2 orders of magnitude. This finding indicated that their antiproliferative activities were not due to some general detergent effect. A follow up experiment in the NCI 60-cell-line panel followed by a COMPARE analysis indicated a previously unknown mechanism of action. Ipomoeassin F and ipomoeassins B and E have been synthesized 6, 7, 8 . Ipomoea muricata, Ipomoea bahiensis and Ipomoea squmosa are from same genus show biological properties such as cardiac depresent, spasmolytic antimicrobial, anticancer, cytotoxic activity 9, 10 .
We have selected from the same genus the plant Ipomoea leari. The Plant belongs to, Family Convolculaceae, is twining perennial vine. This plant is famous as Blue Dawn and morning glory vine with a striking purple-blue color flowers. The flowers open in the morning and fade to magenta in the evening. The Origin of the plant is uncertain, but it is widespread throughout the tropical world and commonly found at hill stations of India like Ooty, Nainital and Mussoorie, scrambling over fences and over woody plants. Ethnopharmacological information available on the plant indicates that the root is used for dysentery, blood pressure and Waker carcinoma 256 in rat 11 .
In view of this ethnopharmacological information on the plant, it was proposed screen Ipomoea leari successive extracts and its fraction(s) for the in vitro and in vivo antioxidant activity using standard procedures.
MATERIALS AND METHODS

Plant material
The 
Extraction procedure
The plant was chopped to small pieces and dried in shade.
The dried root was powdered and passed through sieve no. 20 and extracted (600g) successively with 4.8 L each of nhexane (60-80ºC), chloroform, ethyl acetate and hydromethanolic (1:1) solvents in a Soxhlet extractor for 18-20 h. The extracts were concentrated to dryness under reduced pressure and controlled temperature (40-50ºC).
The n-hexane extract yielded an yellowish green sticky semisolid,(2.37g) The chloroform extract yielded green semisolid (6.07g). The ethyl acetate extract yielded dark blackish green solid (6.73g) and hydromethanolic extract yielded (21.54g), respectively. All the extracts were preserved in a refrigerator till further use.
Isolation and fractionation
The chloroform extract was concentrated and loaded in a column after adsorbing silica gel 60-120 mesh for isolation. About 35 different fractions were collected with different solvent system ranging from low to high polarity by gradient technique. Among all the fractions, the fraction showing good in vitro antioxidant (ILCF-28) was chosen for further studies. Repeated re-column chromatography of ILCF-28 yielded a colourless crystalline compound. This was characterized by melting point, IR, NMR and mass spectrum.
Preparation of test and standard solutions
All the four extracts of Ipomoea leari, fraction ILCF-28 and the standard antioxidants (ascorbic acid, rutin and butylated hydroxy anisole) were dissolved in distilled dimethyl sulphoxide (DMSO) separately and used for the in vitro antioxidant assays using five different methods except the hydrogen peroxide method. For the hydrogen peroxide method (where DMSO interferes with the method), the extracts and the standards were dissolved in distilled methanol and used. The stock solutions were serially diluted with the respective solvents to obtain lower dilutions. A suspension of ILC, ILCF-28 and standard drug silymarin were prepared in sodium CMC (0.5%, w/v) using distilled water and used for in vivo experiments.
Estimation of total phenolic content
The amount of phenolic compounds in all the four extracts was estimated by using Folin-Ciocalteu reagent 12 . In a test tube, 0.4mL of the extract in methanol was taken, mixed with 2 mL of Folin-Ciocalteu reagent and 1.6mL of sodium carbonate. After shaking, it was kept for 2h and the absorbance was measured at 750 nm using a Shimadzu-UV-160 spectrophotometer. Using gallic acid monohydrate, a standard curve was prepared. The linearity obtained was in the range of 1-10 g/mL. Using the standard curve, the total phenolic compounds content was calculated and expressed as gallic acid equivalent in mg/g of the extracts.
Estimation of Total flavonoid content
Aluminum chloride colorimetric method was used for the estimation of flavonoids 13 . The sample (1mL) was mixed with 3 mL of methanol, 0.2 mL of 10% aluminum chloride, 0.2 mL of 1 M potassium acetate and 5.6 mL of distilled water. The mixture was kept at room temperature for 30 minutes and the absorbance of the reaction mixture was measured at 415 nm a with PerkinElmer UV/Visible spectrophotometer. A calibration curve was prepared by preparing quercetin solutions at 20, 40, 60, 80 and 100 µg/mL concentrations in methanol. The concentration of flavonoid was found using the standard curve and the results were expressed as mg of quercetin equivalents (QE) per g dry weight (mg QE/g DW) of the sample.
In vitro antioxidant activity
The four extracts and the fraction ILCF-28 were tested for their in vitro antioxidant activity using standard methods. In all these methods, a particular concentration of the extract or standard solution was used which gave a final concentration of 1000-0.45 g/mL after all the reagents were added. Absorbance was measured against a blank solution containing the extract or standard, but without the reagents. A control test was performed without the extracts or standards. Percentage scavenging and IC 50 values ± S.E.M. (IC 50 value is the concentration of the sample required to inhibit 50% of radical) were calculated.
DPPH radical scavenging method
A 10µL aliquot of the extracts, or the standards was added to 200 µL of DPPH in methanol solution (100 µM) in a 96-well microtitre plate (Tarson Products (P) Ltd., Kolkota, India). After incubation at 37ºC for 20 min, the absorbance of each solution was determined at 490 nm using ELISA reader (Bio-Rad Laboratories Inc., CA, USA, Model 550) 14 .
Nitric oxide radical inhibition assay
The reaction mixture (6 mL) containing sodium nitroprusside (10 mM, 4 mL), phosphate buffer saline (1 mL) and the extract or the standard (1 mL) was incubated at 25ºC for 150 min. After incubation, 0.5mL of the reaction mixture was removed and 1mL of sulphanilic acid reagent (0.33% in 20% glacial acetic acid) was mixed and allowed to stand for 5 min for completion of diazotization reaction and then 1mL of NEDD was added, mixed and allowed to stand for another 30 min in diffused light. The absorbance was measured at 540 nm against the corresponding blank solution in a 96-well microtitre plate (Tarsons Product (P) Ltd., Kolkata, India) using ELISA reader (Bio-Rad Laboratories Inc., Model 550) 15, 16 .
Scavenging of ABTS radical cation
To 0.2 mL of the extract or standard, 1.0 mL of distilled DMSO and 0.16 mL of ABTS solution were added and incubated for 20 min. Absorbance of these solutions were measured spectrophotometrically at 734 nm 17 .
Reducing power assay
The extract (1mL) or the standard was added to 2.5 mL of 1% potassium ferricyanide and the mixture incubated for 20 minutes at 50ºC. Aliquots of trichloroacetic acid (2.5 mL, 10%) was added to the mixture and centrifuged for 10 minutes. The upper layer (2.5 mL) was mixed with 2.5 mL of water and 0.5 mL of 0.1% ferric chloride solution.
Absorbance was measured at 700 nm against the corresponding blank solutions 18 .
Scavenging of hydroxyl radical by p-NDA method
The extracts or the standard in distilled DMSO (0.5 mL) was added to a solution mixture containing ferric chloride (0.1 mM, 0.5 mL), EDTA (0.1 mM, 0.5 mL), ascorbic acid (0.1 mM, 0.5 mL), hydrogen peroxide (2 mM, 0.5 mL) and p-NDA (0.01 mM, 0.5 mL) in phosphate buffer (pH 7.4, 20 mM), to produce a final volume of 3 mL. Absorbance was measured at 440 nm 19 .
Scavenging of hydrogen peroxide
A solution of hydrogen peroxide (20 mM) was prepared in phosphate-buffered saline (PBS at pH 7.4). The extract / standard in methanol (1 mL) was added to 2mL of hydrogen peroxide solution in PBS. After 10 min the absorbance was measured at 230 nm 20 .
In vivo antioxidant activity
Animals were divided into six groups comprising of six animals in each group. Group I served as normal and received 1mL of 0.5% sodium carboxy methyl cellulose (CMC). Group II served as CCl 4 treated control and received 1mL of 0.5% sodium CMC. Groups III received standard silymarin at 100 mg/kg body weight. Group IV, Groups V and VI received the successive chloroform extracts at 100, 200 and 400 mg/kg body weight, respectively. All these treatments were given orally for 7 days. On day 8, except for group I, all the other groups received 1 mL/kg body weight of CCl 4 , intraperitoneally.
On the day 9, the rats were anesthetized using diethyl ether and blood was collected from abdominal artery and kept at 37ºC in the incubator for 30 min. Later, it was cold centrifuged at 2000 rpm for 15 min to get clear supernatant serum, which was used for biochemical estimations. Liver and kidneys were removed, weighed and homogenized immediately with Elvenjan homogenizer fitted with Teflon plunger, in ice-chilled 10% KCl solution (10 mg/g of tissue). The suspension was centrifuged at 2000 rpm at 4
•C for 10 min and the clear supernatant was used for biochemical estimations. Catalase was estimated by following the breakdown of hydrogen peroxide according to the method of beers et al., 21 . Superoxide dismutase (SOD) was assayed based on the inhibition of epinephrine autooxidation by the enzyme 22 . Lipid peroxidation was measured in terms of malondialdehyde (MDA) content following the thiobarbituric acid method 23 .
Statistical analysis
Results were expressed as mean ± S.E.M. Comparisons among the groups were tested by one-way ANOVA using Graph Pad Prism, Version 4.0 (Graph Pad Software, San Diego, CA, USA). When the p-value obtained from ANOVA was significant (p < 0.05), the Tukey test was applied to test for differences among groups.
RESULTS
Isolation of stigmasterol
Total phenolic content estimation
The total phenolic content of the four successive extracts were expressed as gallic acid equivalent in mg/g of extracts. Chloroform extract had the highest phenolic content, namely 29.2±0.8 mg/g, followed by ethyl acetate extract 16.5±0.2 mg/g. Ethyl acetate extract had the highest flavonoid content 4.7±0.1 mg/g followed by chloroform extract 19.2±0.15 mg/g.
In vitro antioxidant assay
The four successive extracts and the fraction ILCF-28 were tested for in vitro antioxidant activity. The results are given in Table I . The data reveal that in the DPPH method potent antioxidant activity was observed for ILCF-28, ILC and ILE with IC 50 value of 19.3 ± 0.91, 25.02 ± 0.05 and 90.69 ± 0.72 g/ml, respectively. ILE and ILHM showed good to moderate antioxidant activity with IC 50 value of 120.20 ± 0.17 and 176.34 ± 0.61 g/ml, respectively. The successive n-hexane extract of Ipomoea leari ILH showed poor antioxidant activity. In the Nitric oxide method, potent antioxidant activity was observed for ILCF-28 with an IC 50 value of 26.72 ± 0.72 g/ml. ILC also showed potent antioxidant activity (but lower than both the standards) with an IC 50 value of 37.97 ± 2.11 g/ml. ILE showed good to moderate antioxidant activity with IC 50 value of 117.12 ± 0.31 and 165.21 ± 0.41 g/ml, respectively. ILH and ILHM show no or weak antioxidant activity. In ABTS method, ILCF-28 exhibited potent antioxidant activity with, IC 50 value of 54.22 ± 1.12 g/ml. ILC also showed potent antioxidant activity with IC 50 value of 65.19 ± 0.21 g/ml. ILC, ILE showed moderate antioxidant activity with IC 50 value of 287.03 ± 1.22 and 310.57 ± 2.01 g/ml, respectively. ILP and ILHM showed weak activity even at the highest concentrations tested.
In the reducing power method ILCF-28 exhibited good antioxidant activity with IC 50 value of 125.15 ± 1.04 g/ml. ILC and ILE, showed moderate antioxidant activity with IC 50 value of 195.31 ± 2.01 and 362.56 ± 0.02 g/ml, respectively. ILH showed no antioxidant activity. ILHM showed weak activity even at high concentrations tested.
In the p-NDA method ILCF-28 exhibited moderate activity with IC 50 value of 341.01 ± 0.32 g/ml. ILC and ILE showed weak activity with IC 50 value of 402.01 ± 0.22 and 589.21 ± 0.55 g/ml, respectively. ILHM showed weak activity even at high concentrations tested.
In H 2 O 2 method ILC-28 exhibited moderate activity with IC 50 value of 480.21 ± 2.01 g/ml. The remaining extracts and fractions are inactive.
In vivo antioxidant assay
ILC and ILCF-28 has showed potent in vitro antioxidant activity compared to other extracts. ILC showed total phenolic content. Hence, ILC was selected for the in vivo antioxidant screening. The administration of ILC at 100, 200 and 400 mg/kg bodyweight for 7 days prior to CCl 4 treatment caused a significant increase in the levels of catalase and SOD and a significant decrease in the levels of LPO in serum, liver and kidney.
In vivo lipid peroxidation
The localization of radical formation resulting in lipid peroxidation is measured as MDA in serum, liver and kidney. MDA content in the serum, liver and kidney significantly increased in CCl 4 
In vivo antioxidant enzymes
The SOD levels of serum, liver and kidney in CCl 4 control group were significantly lower than in normal group (p<0.001). Pretreatment with ILC at the entire three dose levels (100, 200 and 400 mg/kg), however, significantly increased the SOD levels by 31 Catalase activity of CCl 4 control group was seen to be strikingly lower than the normal group (p<0.001).Pretreatment with ILC at all the three dose levels (100, 200 and 400 mg/kg), however, significantly increased the catalase levels by 21.92, 69.79 and 88.19%, respectively for serum, 36.15, 59.50, 86.85 %, respectively for liver and 27.19, 56.61 and 72.09 %, respectively for kidney when compared to CCl 4 control. The percentage increase for silymarin (100 mg/kg) on catalase levels was, however, 85.14, 87.78 and 74.32 %, for serum, liver and kidney, respectively.
The analysis of the results reveal, alterations in the activities of antioxidant enzymes (SOD and catalase), lipid peroxidation, serum, liver and kidney of CCl 4 intoxicated rats. Administration of ILC at 100, 200 and 400 mg/kg for 7 days prior to CCl 4 treatment showed significant protection.
DISCUSSION
CCl 4 hepatotoxicity depends on the reductive dehalogenation of CCl 4 catalysed by Cyt 450 in the liver cell endoplasmic reticulum leading to the generation of an unstable complex CCl3• radical. This trichloromethyl radical has been shown to be a highly reactive species, capable of attacking microsomal lipids leading to its peroxidation. This also covalently binds to microsomal lipids and proteins initiating secondary biochemical processes which is the ultimate cause for the unfolding of the panorama of pathological consequences of CCl 4 metabolism 24 .
Further, oxidative stress, the consequence of an imbalance of pro oxidants and antioxidants in the organism, is also gaining recognition as a key phenomenon in chronic illnesses like inflammation, heart diseases, hypertension and some forms of cancer 25 . ROS produced through mechanism of signaling leads to deleterious effects. Hydrogen peroxide (ROS) has been reported as an important mediator of signaling oriented to the activation of transcription factors which are sensible to redox cycle and activators of responsible genes of cancerigenic cells growth and of some inflammatory processes. Oxidative stress results in toxicity when the rate at which the ROS are generated exceeds the cell capacity for their removal. Lipid peroxidation is an autocatalytic process, which is a common consequence of cell death. This process may cause peroxidative tissue damage in inflammation, cancer and toxicity of xenobiotics and aging. MDA is one of the end products in the lipid peroxidation process 26 .
The data obtained in our present study (Table 2) clearly show an increase in the MDA level in serum, liver and kidney of rats treated with CCl 4 suggesting enhanced lipid peroxidation leading to tissue damage and failure of antioxidant defense mechanisms to prevent formation of excessive free radicals. Treatment with ILC, however, is seen to significantly reverse these changes in a dose dependent manner. ILC at 400 mg/kg significantly (p < 0.001) inhibited the formation of MDA levels in CCl 4 treated group and this is seen to be comparable with the standard drug silymarin.
Biological systems protect themselves against the damaging effects of activated species by several means. These include free radical scavengers and chain reaction terminators; enzymes such as SOD and CAT system 27 . The SOD converts superoxide radicals (O 2 −) into H 2 O 2 plus O 2 , thus participating with other antioxidant enzymes, in the enzymatic defense against oxygen toxicity. The data obtained in the present study (Table 2) reveals that there is an increase of SOD activity in a dose dependent manner suggesting that the ILC has an efficient protective effect in response to ROS. ILC at 400 mg/kg and silymarin at 100 mg/kg significantly (p < 0.001) restores the SOD activity in CCl 4 treated groups.
CAT is a key component of the antioxidant defense system. Inhibition of this protective mechanism results in enhanced sensitivity to free radical induced cellular damage. The reduction in the activity of CAT may, therefore, result in a number of deleterious effects due to the accumulation of superoxide radicals and hydrogen peroxide 28 . The data obtained in the present study reveals that administration of ILC increases the CAT level in CCl 4 induced liver damage to rats thus preventing the accumulation of excessive free radicals and protects the liver from CCl 4 intoxication. ILC at 400 mg/kg and silymarin at 100 mg/kg almost significantly (p < 0.001) restore the enzyme activity to the near normal levels.
During hepatic injury, superoxide radicals generate at the site of damage and modulate SOD and CAT, resulting in the loss of activity and accumulation of superoxide radical, which damages liver. Decreased CAT activity is linked to unexhaustion of the enzyme as a result of oxidative stress caused by CCl 4 . The reduced levels of SOD and CAT, in CCl 4 treated rats, significantly increases when treated with plant extracts thus showing that antioxidant property of the extract 29, 30 .
The phytochemical studies carried out on ILC reveal the presence of carbohydrates, flavonoids, glycosides, steroids and phenols etc. An analysis of the data given in Table 1 reveals that the observed in vitro antioxidant activity of four successive extracts of Ipomoea leari correlates with its phenolic content. A number of scientific reports indicate certain terpenoids, steroids and phenolic compounds such as tannins, coumarins and flavonoids have protective effects due to its antioxidant properties 31, 32, 33, 34 .
In the present study successive chloroform extract, ILC shows the presence of stigmasterol as a major compound which has been shown well to moderate antioxidant activity in different in vitro models by earlier workers 35 . Stigmasterol thus contributes to antioxidant nature of ILC. In conclusion, the present study clearly reveals that ILC has potent in vitro free radicals scavenging effect in different in vitro models and exhibits a dose dependent antioxidant activity by inhibiting lipid peroxidation and enhancing antioxidant enzymes such as SOD and CAT level, in CCl 4 intoxicated rat model. ILC is, therefore, a potential therapeutic, thus making it an excellent candidate for more detailed investigations. 
